Pharma News

Virupaksha Organics Ltd.: A Trusted Manufacturer of Tramadol HCl

Virupaksha Organics Ltd., a leading pharmaceutical manufacturer, has gained recognition for its high-quality production of Tramadol Hydrochloride (HCl), an important pain-relieving medication used globally. Tramadol HCl is widely prescribed for the treatment of moderate to severe pain, making it an essential API (Active Pharmaceutical Ingredient) in pain management therapies.

With cutting-edge manufacturing facilities located in Telangana, India, Virupaksha ensures that its production processes meet the highest international standards of quality, compliance, and safety. The company is certified by WHO-GMP, ISO 9001, and ISO 14001, reflecting its commitment to maintaining best practices in both pharmaceutical production and environmental sustainability.

Virupaksha Organics has invested heavily in R&D and state-of-the-art technology, ensuring the production of cost-effective and high-purity Tramadol HCl to meet global market demands. Through its dedication to quality and innovation, the company has established itself as a trusted partner for pharmaceutical companies worldwide, providing regulatory support and reliable supply chains for Tramadol HCl.

As Virupaksha Organics continues to expand its global footprint, the company remains committed to delivering affordable, effective solutions for pain management, reinforcing its leadership position in the pharmaceutical industry.

Other Update

  • Indian Pharma Supplier Plans $200M Capsule Factory in Atlanta October 22, 2025 9:17 pm Global Atlanta - Georgia An India-based pharmaceutical machinery firm selling in the U.S. for 25 years has chosen metro Atlanta for a $200 million bet on American manufacturing.  ACG, headquartered in Mumbai with sales in 138 countries, plans to hire 200 people as it introduces a …
  • Stocks slide as earnings, trade fears grip Wall Street October 22, 2025 9:13 pm Yahoo Finance US stocks slid on Wednesday as investors fielded the latest wave of earnings in a busy day highlighted by Tesla (TSLA) and IBM (IBM), while assets like crypto and gold (GC=F) continued to struggle in a broad unwind of recent momentum trades. The Dow Jones …
  • Right patenting October 22, 2025 5:04 pm Financial Express A few weeks ago, Commerce and Industry Minister Piyush Goyal quoted a Swiss official as saying that India might attract investments of $150 billion, if it adopted data exclusivity. The minister was hinting at a rethink of the long-held policy of limiting …
  • New Drugs Show Promise In Tough-To-Treat Cancers October 22, 2025 4:22 pm Forbes In this week’s edition of InnovationRx, we look at cancer treatment breakthroughs from ESMO, a high-tech chair that could revolutionize cancer radiation therapy, AI chatbots for seniors, a startup applying ride-share mapping to healthcare navigation, and …
  • Development opportunities showcased at Regional Investment Summit were 'brilliant to see' says leading business figure October 22, 2025 4:13 pm Express & Star The summit, held at Edgbaston Cricket Ground, Birmingham, on Tuesday (October 21) saw £800 million of investment for the West Midlands announced, which will create hundreds of jobs and boost skills across the region. More than 350 business leaders, …
  • GCCs step up as engines of digital transformation October 22, 2025 3:58 pm ETGCC.in Artificial intelligence featured prominently across the discussion, with each leader presenting a distinct perspective on its promise and its perils.A new generation of leaders is reshaping the narrative of India’s Global Capability Centres (GCCs), proving …
  • Markus Engelhard October 22, 2025 3:47 pm Intellectual Asset Management Having lectured for WIPO and trained patent agents from numerous developing countries, what, in your opinion, is the most crucial piece of advice you offer regarding intellectual property strategy?  Maintain a sharp eye for detail but never lose sight of …
  • Q&A: SGD Pharma at CPHI Frankfurt 2025 October 22, 2025 3:41 pm European Pharmaceutical Manufacturer European Pharmaceutical Manufacturer speaks to Carole Grassi, chief commercial marketing & innovation officer, SGD Pharma about what the company is showcasing at CPHI Frankfurt. 1. What will you be showcasing at CPHI?  At CPHI 2025, SGD Pharma is …
  • What A Court Win Says About India’s Generics Case October 22, 2025 3:29 pm The Times of India Explainer on the Risdiplam battle: GOI and Indian pharma must make the most of legitimate TRIPS flexibilities when multinational companies extend patents on life-saving drugs by suspect means Risdiplam is the life-saving drug for a rare disease, Spinal …
  • Torrent Pharma gets CCI nod to acquire majority stake in JB Chemicals October 22, 2025 3:18 pm Mint Gujarat-based pharma major, Torrent Pharmaceuticals, on Tuesday, 21 October 2025, received the approval from India's antitrust regulator, the Competition Commission of India (CCI), to acquire a majority stake in KKR-backed JB Chemicals. According to an …
  • Trailers Market Size to Reach USD 60.36 Billion by 2032 Growth Drivers, Industry Trends Key Players & Regional Insights October 22, 2025 3:01 pm EIN Presswire food service equipment market encompasses a wide range of appliances and machinery used in commercial kitchens and food service establishments worldwide. WILMINGTON, DE, UNITED STATES, October 22, 2025 /⁨EINPresswire.com⁩/ -- Global Trailers …
  • Migraine Drugs Market Projected to Surpass USD 15.54 billion by 2032 Due to Rising Demand – SNS Insider October 22, 2025 2:04 pm Business Upturn NS Insider projects the US market to reach USD 5.80 billion by 2032, driven by increasing prevalence and innovative therapies Austin, Oct. 22, 2025 (GLOBE NEWSWIRE) — Migraine Drugs Market Size & Growth Analysis: According to S&S Insider, the …
  • Abu Dhabi’s Mubadala completes Loscam deal with a 30% stake October 22, 2025 1:35 pm The National News Abu Dhabi’s Mubadala Investment Company has completed a deal to buy a 30 per cent stake in Hong Kong-based logistics solutions provider Loscom International to boost its investments in Asia. The deal, announced in July, marks Mubadala’s first co-control …
  • Torrent Pharma finally gets CCI nod for acquisition of JB Chemicals October 22, 2025 1:15 pm Medical Dialogues New Delhi: Torrent Pharmaceuticals has received the green light from the Competition Commission of India (CCI) for its proposed Rs 19,500 crore acquisition of J.B. Chemicals & Pharmaceuticals, but with voluntary modifications to address potential …
  • USD flat, GBP hit after UK's inflation report and XAU resumes recent downside - Newsquawk US Opening News October 22, 2025 1:10 pm Zero Hedge European bourses are broadly lower, but FTSE 100 outperforms after UK inflation; US equity futures are modestly weaker. USD is flat & GBP hit after region's softer-than-expected inflation report, which has boosted bets for a cut in December. USTs …
  • Futures Flat As Gold Selloff Extends October 22, 2025 1:10 pm Zero Hedge US equity futures are flat again, with tech and small caps lagging as traders parsed the latest earnings reports and corporate news amid worries over trade, the US government shutdown and geopolitical risks. Gold and silver extended declines after Tuesday’ …
  • 'Translation is just the tip of the iceberg': How pharma marketers are reaching Hispanic audiences October 22, 2025 1:04 pm Fierce Pharma The understated green and white box labeled Aspirina that started rolling out in select Walmart and Walgreens locations this summer may strike some Americans as an interesting novelty, a new addition to their pain-relief options. For many Hispanic …
  • Here’s why you should stay invested in the stock market and follow the basics this new Vikram Samvat October 22, 2025 1:03 pm Mint In the 14 months I have been writing this column, I felt compelled to address current market conditions only once before. In ‘Stay put or exit? What should investors do in this market slump,’ (27 February 2025), I wrote, “In short, currently it is time to …
  • How India survived global uncertainty and cut inflation October 22, 2025 12:45 pm The Week India’s economy showed remarkable strength in the second quarter of 2025-26, as inflation dropped to its lowest level since 2017. The best part? This came during a time of mounting global trade tensions and policy uncertainties that created headwinds for …
  • Healthcare Contract Management Software Market to Reach USD 8.84B by 2032 | AI & Cloud Solutions Drive Growth October 22, 2025 12:11 pm EIN Presswire The research gives a comprehensive perspective of the market by combining qualitative and quantitative data. WILMINGTON, DE, UNITED STATES, October 22, 2025 /⁨EINPresswire.com⁩/ -- Global Healthcare Contract Management Software Market Overview …
  • A Wise Prescription for UK–India Growth: Life Sciences Must Lead the Way October 22, 2025 12:08 pm ETPharma.com UK Prime Minister Keir Starmer is on a global mission for growth, with India his latest stop as the Government seeks to expand the reach of free trade agreements with key partners. If he is looking for an injection of economic momentum – for both his …
  • Medical Foods for Orphan Disease Market Projected to Hit USD 14.65 Billion by 2034 at 5.2% CAGR: Towards Healthcare Report October 22, 2025 12:00 pm EIN Presswire Ottawa, Oct. 22, 2025 (GLOBE NEWSWIRE) -- The global medical foods for orphan disease market size was valued at USD 8.84 billion in 2024 and is predicted to hit around USD 14.65 billion by 2034, rising at a 5.2% CAGR, a study published by Towards …
  • Meta appoints Juseleen Jalil as HR Director, APAC October 22, 2025 11:17 am ETHRWorld Southeast Asia Meta has named Juseleen Jalil as its new HR Director for the Asia-Pacific region, tasking her with driving the company’s human resources strategy and operations across the region. She will strengthen Meta’s workforce through innovation, inclusion, and …
  • Trump Steps Up Pressure On Trading Partners Over Drug Costs, Plans Section 301 Review: Report October 22, 2025 9:14 am Asianet Newsable The Trump administration is preparing a Section 301 investigation to assess whether U.S. trading partners underpay for prescription drugs, a move that could pave the way for new tariffs. Earlier this month, the White House confirmed generic drugs would be …
  • Alvotech Announces Changes in Global Business Development and Commercial Operations Team October 22, 2025 9:00 am EIN Presswire REYKJAVIK, Iceland, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced changes to its global business …